The haemodynamic effects of long term felodipine therapy in previously untreated essential hypertension
- PMID: 2095339
- DOI: 10.1007/BF00316091
The haemodynamic effects of long term felodipine therapy in previously untreated essential hypertension
Abstract
Sixteen patients with previously untreated mild/moderate hypertension (WHO Stage I) were studied: 7 women and 9 men, mean age 56.2 y. Haemodynamics, central and pulmonary blood volumes were measured by radionuclide techniques and repeated after 8 weeks felodipine therapy. To achieve a target diastolic blood pressure of less than 95 mm Hg 12 patients required 5 mg bid, 2 10 mg bid and 1 2.5 mg bid; 1 withdrew after 2 weeks. Mean (SD) arterial blood pressure (mm Hg) was 189/106 before, and 182/103 after 2 weeks placebo treatment and fell to 148/84 after 8 weeks felodipine therapy. Relative systemic vascular resistance fell by 19% from 2146 to 1734 dyn.s.cm-5. There were no significant changes in heart rate, cardiac index, total blood volume, pulmonary blood volume or left ventricular ejection fraction. Plasma renin activity did not rise significantly. Short lived vasodilator side effects occurred in 7/16 patients during initial treatment and mild ankle oedema persisted in 4/16 patients. In contrast to the haemodynamic changes seen acutely with felodipine, the only sustained changes after 8 weeks therapy are reductions in systemic vascular resistance and blood pressure.
Similar articles
-
Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders.Drugs. 1992 Aug;44(2):251-77. doi: 10.2165/00003495-199244020-00008. Drugs. 1992. PMID: 1382018 Review.
-
Central and peripheral haemodynamic responses to felodipine in congestive heart failure.Eur J Clin Pharmacol. 1991;41(2):95-8. doi: 10.1007/BF00265898. Eur J Clin Pharmacol. 1991. PMID: 1743253
-
Acute and chronic calcium antagonist treatment elevates sympathetic activity in primary hypertension.Hypertension. 1994 Sep;24(3):287-96. doi: 10.1161/01.hyp.24.3.287. Hypertension. 1994. PMID: 8082934
-
Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group.Drugs. 1987;34 Suppl 3:139-48. doi: 10.2165/00003495-198700343-00030. Drugs. 1987. PMID: 2894973 Clinical Trial.
-
Felodipine/metoprolol: a review of the fixed dose controlled release formulation in the management of essential hypertension.Drugs. 2000 Jan;59(1):141-57. doi: 10.2165/00003495-200059010-00011. Drugs. 2000. PMID: 10718104 Review.
Cited by
-
Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in older patients.Drugs Aging. 1992 Sep-Oct;2(5):374-88. doi: 10.2165/00002512-199202050-00002. Drugs Aging. 1992. PMID: 1392220 Review.
-
Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders.Drugs. 1992 Aug;44(2):251-77. doi: 10.2165/00003495-199244020-00008. Drugs. 1992. PMID: 1382018 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical